Health
Gland Pharma Glaucoma Drug Approval Lifts Shares
David Hale·
109 articles
Psychedelic therapy yields opposite outcomes, healing some while deeply unsettling others, challenging health protocols…
FDA approves the first gene therapy for genetic hearing loss on May 9, 2026, marking a significant advance in treating i…
The global Monkeypox Vaccine Treatment market is forecast to grow at 8.2% CAGR through 2035, driven by endemic risk and…
New findings reveal leukemia stem cells cause treatments to fail, but this breakthrough opens promising avenues to overc…
US Food and Drug Administration blocked publication of studies confirming shingles and COVID-19 vaccine safety, raising…
A Phase 2 human clinical trial for an effective hookworm vaccine has advanced, offering new hope for millions affected b…
A new study reveals UK restaurant chains falling short on healthy nutrition targets, raising concerns for public health…
Tulane University study reveals significant New Orleans youth mental health challenges, prompting calls for enhanced sup…
Rutgers doctoral student coauthored cancer treatment research that could transform oncology, offering new hope in the fi…
FDA proposes a new ultra-rare disease pathway for treatment approval on May 4, 2026, aiming to streamline access for pat…
The global intranasal drug delivery market is seeing record expansion, driven by non-invasive methods and advanced pharm…